Skip to main content
Log in

Maintenance of normocalcemia by continuous infusion of the synthetic bovine parathyroid hormone (1–34) in parathyroidectomized rats

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

This work was conducted to estimate the replacement dose of the synthetic bovine parathyroid hormone [PTH(1–34)] that is required for maintenance of serum calcium (Ca) in parathyroidectomized (PTX) rats. Male rats were PTX and used in this study only if serum Ca was reduced to at least 7 mg/dl. We found that a solution of 2% cysteine, 150 mM NaCl, and 1 mM HCl was superior to 20 mM acetic acid for maintenance of biological activity of PTH (1–34) in situ during the period of hormone infusion studied. The PTH dose—calcemic response relationship was investigated using PTH in doses of 0.6, 1, and 3 U/h. The infusion of 1 U PTH per hour raised Ca to the normal level, whereas rats infused with 0.6 U/h were hypocalcemic and 3 U/h resulted in marked hypercalcemia. To extend this observation we carried out an infusion of 1 U PTH per hour for 14 days. We found that this infusion rate of bovine PTH (1–34) provided a relatively stable level of serum calcium with modest fluctuation from normocalcemic to somewhat hypercalcemic levels for the entire 14-day period of PTH infusion. Serum calcitonin was also elevated during the infusion period and then returned to the initial level when PTH treatment was stopped. After the minipumps containing PTH were removed, the serum Ca dropped rapidly to 5 mg/dl, which was significantly lower than the control (vehicle-infused) or initial values of serum Ca (7 mg/dl). Infusion of PTH at 3 U/h for 4 days did not produce this rebound hypocalcemia after the pumps were removed. Serum Ca in those experiments returned to the initial level after hormone treatment was discontinued.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Keutmann HT, Aurbach GD, Dawson BF, Niall HD, Deftos LJ, Potts JT Jr (1971) Isolation and characterization of the bovine parathyroid hormone. Biochemistry 10:2779–2787

    Article  CAS  PubMed  Google Scholar 

  2. Keutmann, HT, Dawson BF, Aurbach GD, Potts JT Jr (1972) A biologically active amino-terminal fragment of bovine parathyroid hormone prepared by dilute acid hydrolysis. Biochemistry 14:1973–1980

    Article  Google Scholar 

  3. Potts JT Jr, Tregear GW, Keutmann HT, Niall HD, Sauer R, Deftos LJ, Dawson BF, Hogan ML, Aurbach GD (1971) Synthesis of biologically active N-terminal tetratriacontapeptide of parathyroid hormone. Proc Natl Acad Sci USA 68:63–67

    CAS  PubMed  Google Scholar 

  4. Obie JF, Cooper CW (1979) Loss of calcemic effects of calcitonin and parathyroid hormone infused continuously into rats using the Alzet osmotic minipump. J Pharmac Exp Ther 209:422–428

    CAS  Google Scholar 

  5. Marcus R, Aurbach GD (1969) Bioassay of parathyroid hormonein vitro with a stable preparation of adenylate cyclase from rat kidney. Endocrinology 85:801–810

    CAS  PubMed  Google Scholar 

  6. Anast CS, David L, Winnacker J, Glass R, Baskin W, Brubaker L, Burns T (1975) Serum calcitonin lowering effect of magnesium in patients with medullary carcinoma of the thyroid. J Clin Invest 56:1615–1621

    Article  CAS  PubMed  Google Scholar 

  7. Snedecor GW, Cochran WG (1967) Statistical Methods, 6th ed. Iowa State University Press, Ames, p 59

    Google Scholar 

  8. Nickols GA, Carnes DL, Anast CS, Forte LR (1979) Parathyroid hormone-mediated refractoriness of rat kidney cyclic AMP system. Am J Physiol 236:E-401–E-409

    CAS  Google Scholar 

  9. Tregear GW, Rietschoten JV, Greene E, Keutmann HT, Niall HD, Reit B, Parsons JA, Potts JT Jr (1973) Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity. Endocrinology 93:1349–1353

    Article  CAS  PubMed  Google Scholar 

  10. DiBella FP, Arnaud CD, Brewer HB Jr (1976) Relative biologic activities of human and bovine parathyroid hormones and their synthetic NH2-terminal (1–34) peptides, as evaluatedin vitro with renal cortical adenylate cyclase obtained from three different species. Endocrinology 99:429–436

    CAS  Google Scholar 

  11. Herrmann-Erlee MPM, van der Meer JM, Hekkelman JW (1980)In vitro studies of the adenosine 3′,5′-monophosphate (cAMP) response of embryonic rat calvaria to bovine parathyroid hormone-(1–84) (b PTH-(1–84)), bPTH-(1–34), and bPTH-(3–34) and the loss of cAMP responsiveness after prolonged incubation. Endocrinology 106:2013–2018

    CAS  PubMed  Google Scholar 

  12. Takahashi H, Shimazawa E, Horiuchi N, Suda T, Yamashita K, Ogata E (1978) An estimation of the parathyroid secretion rate in vitamin D deficient rats. Horm Metab Res 10:161–167

    Article  CAS  PubMed  Google Scholar 

  13. Premachandra BN, Blumenthal HT (1961) A method for determination of parathyroid secretion rate in the rat. Proc Soc Exp Biol Med 107:842–845

    CAS  PubMed  Google Scholar 

  14. Parfitt AM (1976) The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium, homeostasis, and metabolic bone diseases. Metabolism 25:909–955

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ibrahim, M.M., Forte, L.R. & Thomas, M.L. Maintenance of normocalcemia by continuous infusion of the synthetic bovine parathyroid hormone (1–34) in parathyroidectomized rats. Calcif Tissue Int 34, 553–557 (1982). https://doi.org/10.1007/BF02411303

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02411303

Key words

Navigation